Login
From:
Pulmonary Fibrosis News
(Uncensored)
subscribe
US Patent Awaited for Nuformix's Potential IPF Inhalation Therapy
https://pulmonaryfibrosisnews.com/news/nuformix-nxp002-ipf-inhalation-therapy-awaits-us-patent/
links
backlinks
Tagged with:
patent
ipf
idiopathic pulmonary fibrosis
tranilast
nxp002
nuformix
Nuformix received a notice of allowance from the U.S. Patent Office, and awaits a patent for NXP002, an inhaled form of tranilast for IPF.
Roast topics
Find topics
Find it!
